应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
02005 石四药集团
已收盘 01-13 16:08:13
3.080
+0.040
+1.32%
最高
3.150
最低
3.030
成交量
1,248万
今开
3.030
昨收
3.040
日振幅
3.95%
总市值
89.29亿
流通市值
89.29亿
总股本
28.99亿
成交额
3,870万
换手率
0.43%
流通股本
28.99亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
每日卖空追踪 | 石四药集团 01月12日卖空量成交21万股,卖空比例为3.52%
市场透视 · 01-12 16:30
每日卖空追踪 | 石四药集团 01月12日卖空量成交21万股,卖空比例为3.52%
智通港股股东权益披露|1月12日
智通财经 · 01-12 08:05
智通港股股东权益披露|1月12日
石四药集团于1月9日斥资138.87万港元回购45.6万股
新浪港股 · 01-11 16:42
石四药集团于1月9日斥资138.87万港元回购45.6万股
石四药集团(02005)1月9日斥资138.87万港元回购45.6万股
智通财经 · 01-09
石四药集团(02005)1月9日斥资138.87万港元回购45.6万股
每日卖空追踪 | 石四药集团 01月09日卖空量成交10.8万股,卖空比例为3.22%
市场透视 · 01-09
每日卖空追踪 | 石四药集团 01月09日卖空量成交10.8万股,卖空比例为3.22%
智通港股回购统计|1月9日
智通财经 · 01-09
智通港股回购统计|1月9日
智通港股股东权益披露|1月8日
智通财经 · 01-08
智通港股股东权益披露|1月8日
石四药集团回购113万股 金额341万港元
财中社 · 01-07
石四药集团回购113万股 金额341万港元
石四药(02005)回购112.8万股,总额约340.63万港元
公告速递 · 01-07
石四药(02005)回购112.8万股,总额约340.63万港元
每日卖空追踪 | 石四药集团 01月07日卖空量成交16.6万股,卖空比例为3.78%
市场透视 · 01-07
每日卖空追踪 | 石四药集团 01月07日卖空量成交16.6万股,卖空比例为3.78%
新选择,石四药集团重磅长效降压药获批上市
北京药研汇 · 01-07
新选择,石四药集团重磅长效降压药获批上市
石四药集团(2005)回购150万股股份,总额约446.94万港元
公告速递 · 01-06
石四药集团(2005)回购150万股股份,总额约446.94万港元
石四药集团(02005)1月6日斥资446.94万港元回购150万股
智通财经 · 01-06
石四药集团(02005)1月6日斥资446.94万港元回购150万股
智通港股股东权益披露|1月6日
智通财经 · 01-06
智通港股股东权益披露|1月6日
石四药集团(02005):取得培哚普利氨氯地平片(Ⅲ)(精氨酸培哚普利10mg、苯磺酸氨氯地平5mg)的药品生产注册批件
智通财经 · 01-05
石四药集团(02005):取得培哚普利氨氯地平片(Ⅲ)(精氨酸培哚普利10mg、苯磺酸氨氯地平5mg)的药品生产注册批件
石四药(02005)回购110万股股份,总额约318.76万港元
公告速递 · 01-05
石四药(02005)回购110万股股份,总额约318.76万港元
石四药集团(02005)1月5日斥资318.76万港元回购110万股
智通财经 · 01-05
石四药集团(02005)1月5日斥资318.76万港元回购110万股
智通港股沽空统计|1月5日
智通财经 · 01-05
智通港股沽空统计|1月5日
石四药集团(02005)12月无新增发行或股份变动
公告速递 · 01-02
石四药集团(02005)12月无新增发行或股份变动
每日卖空追踪 | 石四药集团 01月02日卖空量成交13.8万股,卖空比例为15.75%
市场透视 · 01-02
每日卖空追踪 | 石四药集团 01月02日卖空量成交13.8万股,卖空比例为15.75%
加载更多
公司概况
公司名称:
石四药集团
所属市场:
SEHK
上市日期:
--
主营业务:
石四药集团有限公司,前称为利君国际医药(控股)有限公司,是一家主要从事研究、开发、制造及向医院及分销商销售药物产品的投资控股公司。公司的产品主要包括静脉输液的成药、原料药及医用材料。该公司的产品主要包括非聚氯乙烯软袋输液、聚丙烯塑瓶输液和玻璃瓶输液。该公司的产品还包括盐酸倍他司汀、盐酸氨溴索、盐酸罗哌卡因和多索茶碱以及原料药,包括咖啡因、茶碱、氨茶碱、甲硝唑和硝苯地平。
发行价格:
--
{"stockData":{"symbol":"02005","market":"HK","secType":"STK","nameCN":"石四药集团","latestPrice":3.08,"timestamp":1768291693004,"preClose":3.04,"halted":0,"volume":12484000,"delay":0,"floatShares":2899000000,"shares":2899000000,"eps":0.358192,"marketStatus":"已收盘","change":0.04,"latestTime":"01-13 16:08:13","open":3.03,"high":3.15,"low":3.03,"amount":38703300,"amplitude":0.039474,"askPrice":3.08,"askSize":80000,"bidPrice":3.07,"bidSize":56000,"shortable":3,"etf":0,"ttmEps":0.223096,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1768354200000},"marketStatusCode":5,"adr":0,"listingDate":1135008000000,"exchange":"SEHK","adjPreClose":3.04,"dividendRate":0.047078,"openAndCloseTimeList":[[1768267800000,1768276800000],[1768280400000,1768291200000]],"volumeRatio":2.431278,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02005","defaultTab":"news","newsList":[{"id":"2603724523","title":"每日卖空追踪 | 石四药集团 01月12日卖空量成交21万股,卖空比例为3.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603724523","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603724523?lang=zh_cn&edition=full","pubTime":"2026-01-12 16:30","pubTimestamp":1768206625,"startTime":"0","endTime":"0","summary":"石四药集团北京时间01月12日,跌0.33%,卖空量成交21万股,较上一交易日减少60.08%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112164820a4b9d37e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112164820a4b9d37e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02005","BK1191","LU2460026573.USD"],"gpt_icon":0},{"id":"2602565222","title":"智通港股股东权益披露|1月12日","url":"https://stock-news.laohu8.com/highlight/detail?id=2602565222","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602565222?lang=zh_cn&edition=full","pubTime":"2026-01-12 08:05","pubTimestamp":1768176301,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,中加国信、博安生物、复旦张江、置富产业信托、石四药集团、喆丽控股于2026年1月12日进行了最新股东权益披露。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1391356.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","01349","06955","00778","02005","BK1240","LU2460026573.USD","BK1256","02209","BK1161","00899","BK1098","BK1587","BK1114","BK1142"],"gpt_icon":0},{"id":"2602553620","title":"石四药集团于1月9日斥资138.87万港元回购45.6万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2602553620","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602553620?lang=zh_cn&edition=full","pubTime":"2026-01-11 16:42","pubTimestamp":1768120920,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 石四药集团(02005)发布公告,于2026年1月9日,该公司斥资138.87万港元回购45.6万股。\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:卢昱君","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-01-11/doc-inhfxrmn8340016.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02005","LU2460026573.USD","BK1191"],"gpt_icon":0},{"id":"2602232535","title":"石四药集团(02005)1月9日斥资138.87万港元回购45.6万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2602232535","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602232535?lang=zh_cn&edition=full","pubTime":"2026-01-09 16:34","pubTimestamp":1767947647,"startTime":"0","endTime":"0","summary":"智通财经APP讯,石四药集团(02005)发布公告,于2026年1月9日,该公司斥资138.87万港元回购45.6万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1390905.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2460026573.USD","02005","BK1191"],"gpt_icon":0},{"id":"2602588607","title":"每日卖空追踪 | 石四药集团 01月09日卖空量成交10.8万股,卖空比例为3.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602588607","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602588607?lang=zh_cn&edition=full","pubTime":"2026-01-09 16:30","pubTimestamp":1767947426,"startTime":"0","endTime":"0","summary":"石四药集团北京时间01月09日,股价较前一交易日持平,卖空量成交10.8万股,较上一交易日减少57.14%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109163651a7067c0a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260109163651a7067c0a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2460026573.USD","02005","BK1191"],"gpt_icon":0},{"id":"2602731292","title":"智通港股回购统计|1月9日","url":"https://stock-news.laohu8.com/highlight/detail?id=2602731292","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602731292?lang=zh_cn&edition=full","pubTime":"2026-01-09 09:10","pubTimestamp":1767921002,"startTime":"0","endTime":"0","summary":"其中,回购金额最大的为腾讯控股,回购数量103.40 万,回购金额6.36 亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1390704.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02299","00434","02382","00700","02018","09922","01651","02373","01995","02621","01868","01810","01600","02869","02367","TCHmain","02586","09663","02219","01516","08017","02598","06868","02431","00175","00799","03798","06831","06608","02235","02522","06609","09886","01866","09896","09923","03669","00732","02416","00345","03650","00623","00947","01066","02167","06098","02556","02005","02327","09669"],"gpt_icon":1},{"id":"2601387400","title":"智通港股股东权益披露|1月8日","url":"https://stock-news.laohu8.com/highlight/detail?id=2601387400","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601387400?lang=zh_cn&edition=full","pubTime":"2026-01-08 08:05","pubTimestamp":1767830701,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,百心安-B、同景新能源、石四药集团于2026年1月8日进行了最新股东权益披露。股票名称机构名称性质变动前持股变动后持股持股比百心安-BWang Philip Li好仓8524.77 万股8525.77 万股36.17%(最新)36.17%(前次)同景新能源Well Mount Holdings Limited好仓9797.50 万股1.01 亿股8.22%(最新)7.98%(前次)百心安-BWinning Powerful Limited好仓4606.56 万股4607.56 万股19.55%(最新)19.54%(前次)石四药集团曲继广好仓12.30 亿股12.31 亿股41.72%(最新)41.68%(前次)备注:持股数变动有可能因供股、合股、拆股等情况引起,请注意对照实际情况进行辨别。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1390142.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["08326","02005","02185","BK1100","LU2460026573.USD","BK1154","BK1191"],"gpt_icon":0},{"id":"2601875269","title":"石四药集团回购113万股 金额341万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601875269","media":"财中社","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601875269?lang=zh_cn&edition=full","pubTime":"2026-01-07 17:10","pubTimestamp":1767777032,"startTime":"0","endTime":"0","summary":"石四药集团(02005)发布公告,2026年1月7日,公司回购股份113万股,回购金额为341万港元。根据回购授权的决议,公司可回购的股份总数为2.95亿股,已回购股份4993万股,占回购授权决议通过时已发行股份的1.692%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601073611516584.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2460026573.USD","BK1191","02005"],"gpt_icon":0},{"id":"1115057836","title":"石四药(02005)回购112.8万股,总额约340.63万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1115057836","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115057836?lang=zh_cn&edition=full","pubTime":"2026-01-07 16:36","pubTimestamp":1767774985,"startTime":"0","endTime":"0","summary":"石四药集团有限公司于2026年1月7日更新翌日披露报表,公告显示公司当日回购股份1,128,000股,约占现有已发行股份总数的0.039%。本次回购价格区间为每股3.01港元至3.03港元,总耗资约3,406,340港元。回购完成后,公司于2026年1月7日的已发行股本为2,901,185,385股,库藏股数增至49,928,000股,总股份数保持2,951,113,385股。石四药集团有限公司的回购授权由股东于2025年5月16日批准,可根据授权回购最多295,111,338股股份。公司确认此次交易符合香港联交所上市规则及相关法例规定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02005"],"gpt_icon":0},{"id":"2601938155","title":"每日卖空追踪 | 石四药集团 01月07日卖空量成交16.6万股,卖空比例为3.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601938155","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601938155?lang=zh_cn&edition=full","pubTime":"2026-01-07 16:30","pubTimestamp":1767774627,"startTime":"0","endTime":"0","summary":"石四药集团北京时间01月07日,涨0.67%,卖空量成交16.6万股,较上一交易日减少89.08%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107163346a4a6e5d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107163346a4a6e5d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02005","LU2460026573.USD","BK1191"],"gpt_icon":0},{"id":"2601638156","title":"新选择,石四药集团重磅长效降压药获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2601638156","media":"北京药研汇","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601638156?lang=zh_cn&edition=full","pubTime":"2026-01-07 08:01","pubTimestamp":1767744079,"startTime":"0","endTime":"0","summary":"2026年1月5号,据国家药品监督管理局官网最新显示,石家庄四药有限公司申报的培哚普利氨氯地平片(Ⅲ)获批上市,视同过评。氨氯地平通过选择性抑制血管平滑肌细胞膜上的L型钙通道,减少钙离子内流,从而扩张外周动脉和冠状动脉,降低血压并改善心肌供血。两者在作用机制上产生协同效应,共同实现长效且稳定的血压控制。石四药集团申报的培哚普利氨氯地平片(Ⅲ)成功获批上市,必将为广大高血压患者提供更多的治疗选择。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107082215a6fc1a1c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107082215a6fc1a1c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02005","BK1191","LU2460026573.USD"],"gpt_icon":0},{"id":"1187123090","title":"石四药集团(2005)回购150万股股份,总额约446.94万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1187123090","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187123090?lang=zh_cn&edition=full","pubTime":"2026-01-06 16:37","pubTimestamp":1767688627,"startTime":"0","endTime":"0","summary":"石四药集团有限公司于2026年1月6日发布翌日披露报表,披露了最新股份购回事宜。公告显示,于2026年1月6日,石四药集团通过香港联交所回购股份150万股,约占购回前已发行股本的0.052%。本次回购的价格区间介乎每股2.96港元至3港元,总金额约446.94万港元。回购完成后,石四药集团已发行股份数目降至2,902,313,385股,库存股份增至48,800,000股,总发行股本保持在2,951,113,385股。本次公告由执行董事兼公司秘书周兴扬签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02005"],"gpt_icon":0},{"id":"2601867123","title":"石四药集团(02005)1月6日斥资446.94万港元回购150万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2601867123","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601867123?lang=zh_cn&edition=full","pubTime":"2026-01-06 16:35","pubTimestamp":1767688508,"startTime":"0","endTime":"0","summary":"智通财经APP讯,石四药集团(02005)发布公告,该公司于2026年1月6日斥资446.94万港元回购150万股股份,每股回购价格为2.96-3港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1389285.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2460026573.USD","BK1191","02005"],"gpt_icon":0},{"id":"2601855441","title":"智通港股股东权益披露|1月6日","url":"https://stock-news.laohu8.com/highlight/detail?id=2601855441","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601855441?lang=zh_cn&edition=full","pubTime":"2026-01-06 08:05","pubTimestamp":1767657902,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,首程控股、狮腾控股、天成控股、华新建材、石四药集团于2026年1月6日进行了最新股东权益披露。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1388984.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02110","02562","LU2460026573.USD","BK1191","00697","02005","06655","BK1109","BK1216","BK1135"],"gpt_icon":1},{"id":"2601500444","title":"石四药集团(02005):取得培哚普利氨氯地平片(Ⅲ)(精氨酸培哚普利10mg、苯磺酸氨氯地平5mg)的药品生产注册批件","url":"https://stock-news.laohu8.com/highlight/detail?id=2601500444","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601500444?lang=zh_cn&edition=full","pubTime":"2026-01-05 17:13","pubTimestamp":1767604397,"startTime":"0","endTime":"0","summary":"智通财经APP讯,石四药集团(02005)发布公告,集团已取得中国国家药品监督管理局有关培哚普利氨氯地平片(Ⅲ)(精氨酸培哚普利10mg、苯磺酸氨氯地平5mg)的药品生产注册批件,属于化学药品第4类,视同通过一致性评价。培哚普利氨氯地平片(Ⅲ)是复方制剂,主要用于单药治疗不能充分控制高血压的成人患者,或作为替代疗法用于在相同剂量水平的培哚普利和氨氯地平联合治疗下病情得以控制的原发性高血压。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1388687.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"石四药集团(02005):取得培哚普利氨氯地平片(Ⅲ)(精氨酸培哚普利10mg、苯磺酸氨氯地平5mg)的药品生产注册批件","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02005","LU2460026573.USD","BK1191"],"gpt_icon":0},{"id":"1179468277","title":"石四药(02005)回购110万股股份,总额约318.76万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1179468277","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179468277?lang=zh_cn&edition=full","pubTime":"2026-01-05 16:31","pubTimestamp":1767601885,"startTime":"0","endTime":"0","summary":"石四药集团有限公司于2026年1月5日发布翌日披露报表,披露当日通过香港联合交易所回购股份1,100,000股,占当日公司已发行股本约0.038%。本次回购价格区间为每股2.89港元至2.92港元,合计支付约3,187,620港元。该回购依据公司于2025年5月16日获股东大会通过的购回授权进行,授权可回购股份数为295,111,338股,截至目前,公司已累计回购47,300,000股,占授权通过当日已发行股本的1.603%。公司确认已遵守相关上市规则及法律法规办理本次回购事宜。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02005"],"gpt_icon":0},{"id":"2601900921","title":"石四药集团(02005)1月5日斥资318.76万港元回购110万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2601900921","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601900921?lang=zh_cn&edition=full","pubTime":"2026-01-05 16:27","pubTimestamp":1767601671,"startTime":"0","endTime":"0","summary":"智通财经APP讯,石四药集团(02005)发布公告,于2026年1月5日,该公司斥资318.76万港元回购110万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1388630.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02005","LU2460026573.USD","BK1191"],"gpt_icon":0},{"id":"2601078935","title":"智通港股沽空统计|1月5日","url":"https://stock-news.laohu8.com/highlight/detail?id=2601078935","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601078935?lang=zh_cn&edition=full","pubTime":"2026-01-05 08:20","pubTimestamp":1767572418,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,华润啤酒-R、京东健康-R、联想集团-R上一交易日沽空比率位于前三位,分别为100.00%、100.00%、79.45%。百度集团-SW、阿里巴巴-W、腾讯控股的沽空金额位居前三,分别为17.93 亿元、11.44 亿元、9.62 亿元。香格里拉(亚洲)、旭辉控股集团、复星国际的偏离值位居前三,分别为59.71%、59.32%、43.94%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1388418.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00069","00700","00004","09999","00884","AAGIY","HYDD.SI","82333","89888","HMTD.SI","BYDDY","02005","09988","01299","02228","06969","89988","01929","HTCD.SI","06618","00656","BABA","03143","01066","86618","ALBmain","BIDU","601318","81299","HBBD.SI","80992","TCHmain","PNGAY","81211","HXXD.SI","02318","002594","81810","03968","02423","82318","80291","09888","00576","01918","HPAD.SI"],"gpt_icon":1},{"id":"1186953868","title":"石四药集团(02005)12月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1186953868","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186953868?lang=zh_cn&edition=full","pubTime":"2026-01-02 16:41","pubTimestamp":1767343292,"startTime":"0","endTime":"0","summary":"石四药集团有限公司于2026年1月2日发布2025年12月股份变动月报表。报告期内,公司注册股本维持为10,000,000,000股,面值每股0.02港元,注册股本总额2亿港元未发生变动。截至2025年12月31日,公司已发行的普通股数量为2,904,913,385股,另有46,200,000股以库藏方式持有,合计2,951,113,385股,与上月底保持一致。报告期内未有新增发行、购回或注销股份,也无其他实质性股份变动。当月未有涉及期权行使而导致股份变动的记录。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02005"],"gpt_icon":0},{"id":"2600090597","title":"每日卖空追踪 | 石四药集团 01月02日卖空量成交13.8万股,卖空比例为15.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2600090597","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600090597?lang=zh_cn&edition=full","pubTime":"2026-01-02 16:30","pubTimestamp":1767342627,"startTime":"0","endTime":"0","summary":"石四药集团北京时间01月02日,涨1.06%,卖空量成交13.8万股,较上一交易日减少90.97%更多个股卖空数据请看下面视窗:卖空数据是观测市场多空博弈的关键指标:短期可反映市场情绪,高卖空比例预示看空预期,但极端值可能触发轧空反弹;长期结合基本面恶化则预警下行风险。需注意其局限性:卖空行为包含对冲需求,未必单纯看空;机构可能通过衍生品做空未体现在数据中,且散户跟风易扭曲信号。股市有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260102163259a6eb2a01&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260102163259a6eb2a01&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02005","LU2460026573.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ssygroup.com.hk","stockEarnings":[{"period":"1week","weight":0.0411},{"period":"1month","weight":0.0167},{"period":"3month","weight":0.0667},{"period":"6month","weight":0.0267},{"period":"1year","weight":0.004},{"period":"ytd","weight":0.0742}],"compareEarnings":[{"period":"1week","weight":0.0099},{"period":"1month","weight":0.0243},{"period":"3month","weight":0.0459},{"period":"6month","weight":0.0853},{"period":"1year","weight":0.3957},{"period":"ytd","weight":0.0382}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"石四药集团有限公司,前称为利君国际医药(控股)有限公司,是一家主要从事研究、开发、制造及向医院及分销商销售药物产品的投资控股公司。公司的产品主要包括静脉输液的成药、原料药及医用材料。该公司的产品主要包括非聚氯乙烯软袋输液、聚丙烯塑瓶输液和玻璃瓶输液。该公司的产品还包括盐酸倍他司汀、盐酸氨溴索、盐酸罗哌卡因和多索茶碱以及原料药,包括咖啡因、茶碱、氨茶碱、甲硝唑和硝苯地平。","yearOnYearQuotes":[{"month":1,"riseRate":0.52381,"avgChangeRate":0.00966},{"month":2,"riseRate":0.55,"avgChangeRate":0.025906},{"month":3,"riseRate":0.7,"avgChangeRate":0.087461},{"month":4,"riseRate":0.5,"avgChangeRate":0.035812},{"month":5,"riseRate":0.45,"avgChangeRate":0.00985},{"month":6,"riseRate":0.5,"avgChangeRate":0.067908},{"month":7,"riseRate":0.35,"avgChangeRate":-0.027819},{"month":8,"riseRate":0.35,"avgChangeRate":-0.017769},{"month":9,"riseRate":0.3,"avgChangeRate":-0.04678},{"month":10,"riseRate":0.45,"avgChangeRate":-0.001982},{"month":11,"riseRate":0.65,"avgChangeRate":0.086372},{"month":12,"riseRate":0.5,"avgChangeRate":-0.009169}],"exchange":"SEHK","name":"石四药集团","nameEN":"SSY GROUP"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"石四药集团(02005)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供石四药集团(02005)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"石四药集团,02005,石四药集团股票,石四药集团股票老虎,石四药集团股票老虎国际,石四药集团行情,石四药集团股票行情,石四药集团股价,石四药集团股市,石四药集团股票价格,石四药集团股票交易,石四药集团股票购买,石四药集团股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"石四药集团(02005)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供石四药集团(02005)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}